- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Platelet-activating factor acetylhydrolaseh levels elevated in semen of men with spinal cord injury
Platelet-activating factor [1-O-alkyl-2-acetyl-sn-glycero-3- phosphocholine; PAF] is present in human sperm and its content has a significant and positive relationship with motility. PAF-acetylhydrolase (PAFah), the enzyme that removes the acetyl group (responsible for PAF’s activity), is present in semen and serves as a decapacitating factor. Semen from men with spinal cord injury (SCI) contains sperm with poor motility and this condition may be a result of abnormal PAFah activity in the semen. The study objective was to determine the relationship between PAFah content in semen and sperm motility in men with SCI compared to non-SCI men.
Using a between-subjects design, semen PAF-AH activity was compared in semen specimens from control versus SCI subjects. PAFah activity levels were correlated with sperm motility in each group.
Semen was obtained from 10 men with SCI and 10 age-matched healthy fertile men as control subjects. Sperm motility was determined (WHO, 1999) prior to measurement of PAFah activity (spectrophotometric analysis; AZWELL Inc, Japan). Data were analyzed by Student’s t-test and linear regression.
Mean (±SEM) seminal PAFah content was significantly higher in SCI subjects (1,068.4 ± 163.78 IU/L, range 589.0 - 1,881 IU/L) compared to controls (413.5 ± 40.99 IU/L; range 192.0 - 691.0 IU/L, p < 0.001). Mean sperm motility was significantly lower in SCI subjects (27.9
PAFah activity levels are elevated in semen of men with SCI compared to age-matched healthy control subjects. PAFah was negatively correlated with sperm motility in SCI and control subjects. Additional studies will elucidate the role of PAFah in semen on sperm motility and determine if high PAFah activity contributes to low sperm motility in men with SCI.
Source: Zhu, N. L. Brackett, T. Aballa, D. B; FERTILITY & STERILITY doi:10.1016/j.fertnstert.2004.07.221
MBBS, MD Obstetrics and Gynecology
Dr Nirali Kapoor has completed her MBBS from GMC Jamnagar and MD Obstetrics and Gynecology from AIIMS Rishikesh. She underwent training in trauma/emergency medicine non academic residency in AIIMS Delhi for an year after her MBBS. Post her MD, she has joined in a Multispeciality hospital in Amritsar. She is actively involved in cases concerning fetal medicine, infertility and minimal invasive procedures as well as research activities involved around the fields of interest.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751